2 research outputs found
Expression of constructs of WT--cardiac actin and its mutants in different cell lines and primary rat cardiac myocytes
Das Ziel dieser Arbeit war Untersuchung von Mutationen des kardialen -Aktins, die in manchen Fällen der hypertrophen Kardiomyopathie (HCM) gefunden wurden. Mit Konstrukten, die N-terminal einen GFP- (grün fluoreszierte Protein) oder einen Hemagglutinin tag erzeugten, wurden Wildtyp (WT) und die zwei Mutanten - Y166C und M305L - des kardialen -Aktins zunächst fibroblastische NIH3T3, Kardiomyozyten ähnliche HL-1 und humane A431 (epidermoide Tumor-) Zellen transfiziert. Die Ergebnisse dieser Untersuchungen waren widersprüchlich. Die Y166C-Mutante mit GFP konnte intrazellulär nicht polymerisieren, jedoch mit dem HA-tag war diese Mutante fähig zu polymerisieren. Um primäre Cardiomyocyten zu transfizieren wurden zwei rekombinante adenovirale Konstrukte (WT und Y166C) hergestellt. In Herzmuskelzellen konnten WT und die Y166C-Mutante sehr gut polymerisieren und sich in sarkomerische Strukturen einbauen. Jedoch erzeugte die Y166C Mutante kürzere Sarkomere im Vergleich zu WT-kardialem -Aktin
Integration of cardiac actin mutants causing hypertrophic (p.A295S) and dilated cardiomyopathy (p.R312H and p.E361G) into cellular structures
The human mutant cardiac -actins p.A295S or p.R312H and p.E361G, correlated with hypertrophic or dilated cardiomyopathy, respectively, were expressed by the insect cell system and purified to homogeneity. The purified cardiac actins maintained their native state but showed differences in -sensitivity to stimulate the myosin-subfragment1 ATPase. Here we analyzed the interactions of these c-actins with actin-binding and -modifying proteins implicated in cardiomyocyte differentiation. We demonstrate that Arp2/3 complex and the formin mDia3 stimulated the polymerization rate and extent of the c-actins, albeit to different degrees. In addition, we tested the effect of the MICAL-1 monooxygenase, which modifies the supramolecular actin organization during development and adaptive processes. MICAL-1 oxidized these c-actin variants and induced their de-polymerization, albeit at different rates. Transfection experiments using MDCK cells demonstrated the preferable incorporation of wild type and p.A295S c-actins into their microfilament system but of p.R312H and p.E361G actins into the submembranous actin network. Transduction of neonatal rat cardiomyocytes with adenoviral constructs coding HA-tagged c-actin variants showed their incorporation into microfilaments after one day in culture and thereafter into thin filaments of nascent sarcomeric structures at their plus ends (Z-lines) except the p.E361G mutant, which preferentially incorporated at the minus ends